IBT-B Infant Bacterial Therapeutics AB (publ)

6.843USD69.40 SEK · STO-2.25%Mkt Cap: 92.19M USDP/E: —

Infant Bacterial Therapeutics AB (publ) operates as a clinical stage pharmaceutical company develops and markets drugs to prevent serious neonatal diseases affecting premature infants in Sweden. The company's lead drug c…